Fibrocor's Chief Scientific Advisor, Piet Wigerinck, is attending the IPF Summit in Boston, MA, from August 20th to 22nd as a featured speaker. On Thursday, August 22nd, at 1:30 PM EST, Piet will present on "Blocking the Matrix Stiffness Signal: From Patient to Clinical Candidate." Join us for this insightful discussion! Piet Wigerinck William Newsome
Fibrocor Therapeutics
Biotechnology Research
Toronto, M5G 0B7 548 followers
Targeting Fibrosis Through the Lens of Disease Progression
About us
We develop clinically driven, first-in-class, tissue-specific therapeutics from human diseased tissue to treat specific fibrotic disease populations.
- Website
-
https://fibrocor.com
External link for Fibrocor Therapeutics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Toronto, M5G 0B7
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Fibrotic Disease
Locations
-
Primary
Get directions
661 University Ave
Suite 1300
Toronto, M5G 0B7 M5G 0B7, CA
Employees at Fibrocor Therapeutics
-
Bill Fanslow
Senior Vice President Therapeutic Drug Discovery and Development at Fibrocor Therapeutics
-
Philippe Alen
Senior Vice President, Head of Business Development
-
Adeola Raimi MBA, CPA, CGA, FCCA
Director of Finance
-
John Vittoria CPA, CMA, CGMA
CEO / Founder at Vittoria & Vittoria, LLC
Updates
-
Toby Maher, Professor of Clinical Medicine at the University of Southern California, provides valuable insights into pulmonary fibrosis and highlights how Fibrocor is pioneering a novel approach to treat this condition. Toby will be attending the IPF Summit in Boston, MA from August 20th - 22nd as one of the 2024 Thought Leaders! William Newsome Toby Maher
-
Tune in to the short segment below where CEO and President, William Newsome, discusses Fibrocor's innovative approach to fibrosis research. Discover how Fibrocor Therapeutic's unique strategies are driving us closer to transformative solutions for fibrosis patients. William will be attending the IPF Summit in Boston, MA August 20th - 22nd. Join us in making a difference! William Newsome Piet Wigerinck
-
We are thrilled to announce that Piet Wigerinck, Chief Scientific Advisor of Fibrocor Therapeutics, will be a featured speaker at the IPF Summit in Boston, MA taking place from August 20th - 22nd! Watch the video below to discover Piet's journey and insights into his career in the Pharmaceutical industry. Piet Wigerinck William Newsome
-
We are thrilled to be part of BIOTECanada, a community that champions innovation and excellence in biotechnology. Joining BIOTECanada marks a significant milestone for us as we continue to push the boundaries of medical research and innovation. We look forward to collaborating with fellow members and contributing to the collective mission of improving patient outcomes through cutting-edge biotechnology. #FibrocorTherapeutics #BIOTECanada #PrecisionMedicine #FibrosisResearch #BiotechnologyInnovation
A warm welcome to Fibrocor Therapeutics as they join the growing BIOTECanada membership! Fibrocor Therapeutics is a pioneering company at the forefront of precision medicine, focused explicitly on fibrosis, a complex and debilitating disease. Their groundbreaking approach involves tissue-specific therapeutics to transform the treatment of this complex condition. By partnering with renowned research institutes in Toronto, Canada, they have gathered and extensively studied diseased fibrotic tissue samples from multiple organ systems. Driven by an in-depth comprehension of the disease’s origins and manifestations, they have successfully curated a robust pipeline of drug candidates to address these debilitating conditions within an expanding population of affected patients. Read more about Fibrocor here: https://fibrocor.com/ For BIOTECanada’s full membership listing, visit: https://lnkd.in/dvc8X94n #biotech #newmember #ecosystem #biotechnology #toronto #fibrosis
-
-
We are thrilled to unveil our latest commercial, showcasing the innovative spirit and cutting-edge solutions that make Fibrocor a leader in the industry! This isn't just a commercial—it's a glimpse into the future of technology and connectivity. Click below to watch and discover how we're transforming possibilities into realities. Prepare to be inspired. Fibrocor Therapeutics, Piet Wigerinck, William Newsome
-
A heartfelt thank you to PJ Moynihan and the entire team at Berkshire Innovation Center for providing a fantastic platform for Bill Newsome of Fibrocor Therapeutics to share his story on the BIC Presents podcast. We are excited about the possibilities ahead for biotech innovation in our region. Thank you, PJ and BIC, for making this meaningful conversation possible! #Biotech #FibrosisResearch #BerkshireInnovation #BICPodcast #fibrosis
New #Podcast Alert! Our latest installment of the BIC Presents podcast entitled “Prospecting for Biotech” is a discussion with William Newsome from Fibrocor Therapeutics, a BIC Stage 2 Accelerator company. A Monument Mountain Regional High School and Berkshire Community College alumni, Newsome discusses the path which lead him into a career in #Biotech, Fibrocor's work treating diseases of #fibrosis, and the prospect of bringing Biotech to the #Berkshires. Listen or share today on Spotify or wherever you get your podcasts - https://lnkd.in/eMKvmj9j Thank you to our partners at Massachusetts Clean Energy Center, 1Berkshire, MassMEDIC , Hamilton, Brook, Smith & Reynolds, P.C., Mill Town Foundation, and Pittsfield Economic Revitalization Corporation for supporting our Stage 2 Accelerator program #InTheBerkshires. Stay tuned for application info about our next cohort of accelerator companies coming soon! #IPF #IdiopathicPulmonaryFibrosis #Biotechnology #AlportSyndrome #LungDisease #KidneyDisease #LifeSciences Marianna Saporito Piet Wigerinck Richard E. Gilbert Toby Maher PJ Moynihan Nathan Christy
-
-
What an incredible experience at the 24th Bio€quity Europe conference in beautiful San Sebastián, Spain! From thought-provoking sessions to dynamic networking opportunities, Bio€quity Europe has shown why it's a must-attend event for the biotech and investment communities. Piet and I were thrilled to connect with so many brilliant minds who share our passion for advancing medical science and improving patient outcomes. Fibrocor Therapeutics is proud to be at the forefront of medical innovation, driving forward groundbreaking research and transformative therapies. Our time here has reinforced the critical importance of investing in the future of healthcare. Together, we can push the boundaries of what's possible and make a lasting impact on global health. A heartfelt thank you to everyone who made this event unforgettable. Here's to the partnerships forged and the exciting journey ahead! #BioEquityEurope #InvestInHealth #HealthcareInnovation #Fibrocor
-
Investing in the future of healthcare has never been more important. Join us in San Sebastián, Spain, for the 24th Bio€quity Europe conference, where Fibrocor will be at the forefront of medical innovation. Register and book a meeting with us: https://lnkd.in/dzunkQc #BioEquityEurope #InvestInHealth William Newsome Piet Wigerinck Marianna Saporito
-
-
This is a moment worth celebrating, and we’re beyond proud of our team’s hard work. Can’t wait to see where this journey takes us next. You can catch the full episode at https://lnkd.in/drwcCtYc Toby Maher, Piet Wigerinck, Richard E. Gilbert, William Newsome, PJ Moynihan, Marianna Saporito
-